CLINICAL_TRIALS
trial_result
· 2017-03-01
Clinical Trial Update: S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery [Phase 2]
Summary
Phase 2 trial investigating everolimus for pleural malignant mesothelioma that is unresectable.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-01